Service de Néphrologie-Dialyse-Transplantation, Hôpital Pasteur, CHU de Nice, Nice, France.
Am J Nephrol. 2013;37(4):359-69. doi: 10.1159/000348822. Epub 2013 Mar 23.
Dialysis registries have reported a low take-up of home treatment. The aim of our study was to report patients' preferred treatment options for end-stage renal disease (ESRD) after information delivery, patients' characteristics by treatment preference, and the reasons for differences between treatment preference and the treatment delivered.
A prospective cohort study on patients seen in our nephrology department between January 2009 and June 2011 included all patients with chronic kidney disease (GFR <20 ml/min/1.73 m(2)) and incident dialysis patients who received an information program about ESRD treatment options.
228 patients received information delivery and either expressed a preference for a given renal replacement therapy (peritoneal dialysis, PD: 42%; hemodialysis, HD: 33%), remained undecided (20%) or expressed reluctance to undergo renal replacement therapy (5%). Multivariate analysis revealed that compared to HD preference, patients preferring PD were older (OR 1.02, 95% CI 1.0-1.04), had a lower BMI (OR 0.9, 95% CI 0.87-0.98) and were more likely to have been informed before rather than after starting dialysis (OR 3.4, 95% CI 1.5-7.4); home treatment was the main reason given for preferring PD. Undecided patients were mainly women and the majority were eventually treated by HD. Reluctant patients were the oldest (OR 1.12, 95% CI 1.02-1.22) and were rarely treated by dialysis. Only 24% of patients informed before and 8% of patients informed after starting dialysis were ultimately treated with PD. Reasons for a mismatch between dialysis modality preference and treatment delivered were equally distributed between medical and nonmedical.
Patients should be systematically informed before starting dialysis, patients' preferences should be taken into account before organizing dialysis and all treatment modalities should be available in all centers.
透析登记处报告称,在家中接受治疗的患者比例较低。我们的研究旨在报告信息传递后患者对终末期肾病(ESRD)的首选治疗方案、按治疗偏好划分的患者特征,以及治疗偏好与实际治疗之间差异的原因。
本前瞻性队列研究纳入了 2009 年 1 月至 2011 年 6 月在我们肾病科就诊的所有慢性肾脏病(GFR <20 ml/min/1.73 m(2)) 和开始透析的患者,这些患者接受了有关 ESRD 治疗选择的信息计划。
228 例患者接受了信息传递,表达了对特定肾脏替代治疗的偏好(腹膜透析,PD:42%;血液透析,HD:33%)、未作决定(20%)或不愿意进行肾脏替代治疗(5%)。多变量分析显示,与 HD 偏好相比,PD 偏好的患者年龄更大(OR 1.02,95%CI 1.0-1.04)、BMI 更低(OR 0.9,95%CI 0.87-0.98),并且更有可能在开始透析之前而不是之后接受信息(OR 3.4,95%CI 1.5-7.4);家庭治疗是首选 PD 的主要原因。未作决定的患者主要是女性,大多数最终接受 HD 治疗。不愿意接受透析治疗的患者年龄最大(OR 1.12,95%CI 1.02-1.22),很少接受透析治疗。只有 24%在开始透析前接受信息的患者和 8%在开始透析后接受信息的患者最终接受 PD 治疗。透析模式偏好与实际治疗不匹配的原因在医学和非医学方面分布均匀。
应在开始透析前系统地通知患者,在安排透析前应考虑患者的偏好,并在所有中心提供所有治疗方式。